Health · 1 sources covering this

STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and more

Pfizer hasn't complied with a request to donate emergency penicillin to state health agencies as a backstop to prevent congenital syphilis

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and more
Pfizer hasn't complied with a request to donate emergency penicillin to state health agencies as a backstop to prevent congenital syphilis
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/6c6f39ca61d794e95c6fbda1d4100ab2546beb68"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about Pfizer&#8217;s emergency penicillin program, a Sanofi diabetes drug, and more"></iframe>

STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and more

How 1 sources are covering this

STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and more

More from Health

STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end

STAT+: A key European clinical trial registry lacks complete and timely results, an analysis finds

Covid vaccination cut risk of adverse heart events, large study finds

STAT+: Lilly’s Ajax acquisition may have been worth it

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Pharmalittle: We&#8217;re reading about Pfizer&#8217;s emergency penicillin program, a Sanofi diabetes drug, and more

More from Health

STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end

STAT+: A key European clinical trial registry lacks complete and timely results, an analysis finds

Covid vaccination cut risk of adverse heart events, large study finds

STAT+: Lilly&#8217;s Ajax acquisition may have been worth it

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and more

STAT+: Lilly’s Ajax acquisition may have been worth it